PEDRO TOMAS RAMIREZ to Adrenergic beta-Antagonists
This is a "connection" page, showing publications PEDRO TOMAS RAMIREZ has written about Adrenergic beta-Antagonists.
Connection Strength
0.149
-
Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer. Cancer. 2015 Oct 01; 121(19):3444-51.
Score: 0.112
-
Prospective pilot trial with combination of propranolol with chemotherapy in patients with epithelial ovarian cancer and evaluation on circulating immune cell gene expression. Gynecol Oncol. 2019 09; 154(3):524-530.
Score: 0.037